Drug Information Association Logo
Corporate Tagline

Podium Pearls

Track:
Medical Communications

Day & Time:
March 20, 10:00AM - 11:30AM

Room Number:
Akimel One/Two

Type:
Session

Title:
Podium Pearls

Chair(s):
Stacey M. Fung, PharmD
Associate Director, Medical Communications
Genentech, A Member of the Roche Group, United States

Description:
In this session, Medical Communications Professionals were invited to present their successes, challenges, and “pearls of wisdom” on various topics through podium presentations. Six presentation topics were selected from submitted abstracts for this unique opportunity to share podium pearls.

Presentation(s) & Speaker(s):
Assessing New and Emerging Roles of Medical Communication Professionals in Bio-Pharmaceutical Industry Settings: Evolution from Supporting to a Leading Role
Dannis Y. Chang, PharmD
Medical Communications Scientist
Genentech, A Member of the Roche Group, United States

New Communication Channels and Tools: An Overview and Trends in Adoption and Implementation
Renard DuBois, PharmD
Associate Scientist, Medical Communications
Genentech, A Member of the Roche Group, United States

Globalization Pilot-Transforming US Medical Information Services (MIS)
Joyce P. Fairclough, PharmD
Manager, Metabolism & Medical Information Services
Sanofi, United States

Enhanced Medical Information Website Increases Site Utilization
Steven Hays, PharmD,MBA
Associate Director, Medical Information
Pfizer Inc., United States

In-house Conversion of Medical Information Services from an External Vendor: Implementation and Outcomes
Hadley Le, PharmD
Associate Manager, Medical Information
Gilead Sciences, Inc., United States

Responding to Medical Information Inquiries More Efficiently: What’s Involved When the Process has Regulatory Implications?
Krupa Paranjpe
Associate Director, Medical Information
Pfizer Inc., United States

© 2013 DIA